Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection

Membranous nephropathy (MN) is currently classified as either primary – often associated with positive anti-phospholipase-A2 receptor (PLA2R) autoantibodies – or as secondary – associated with malignancy, infection, medications, or autoimmune disease. We present a case of biopsy-proven MN with very...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lyle W. Baker, Jaime Jimenez-Lopez, Xochiquetzal J. Geiger, Nabeel Aslam
Formato: article
Lenguaje:EN
Publicado: Karger Publishers 2021
Materias:
Acceso en línea:https://doaj.org/article/233a25bf3d4949f692b2b338038fcfc1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:233a25bf3d4949f692b2b338038fcfc1
record_format dspace
spelling oai:doaj.org-article:233a25bf3d4949f692b2b338038fcfc12021-12-02T12:40:23ZMalignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection2296-970510.1159/000520399https://doaj.org/article/233a25bf3d4949f692b2b338038fcfc12021-11-01T00:00:00Zhttps://www.karger.com/Article/FullText/520399https://doaj.org/toc/2296-9705Membranous nephropathy (MN) is currently classified as either primary – often associated with positive anti-phospholipase-A2 receptor (PLA2R) autoantibodies – or as secondary – associated with malignancy, infection, medications, or autoimmune disease. We present a case of biopsy-proven MN with very high serum titer of anti-PLA2R autoantibodies in a patient with a synchronous diagnosis of poorly differentiated esophageal adenocarcinoma and renal cell carcinoma who presented with nephrotic syndrome. Based on the current classification, MN in the presence of active malignancy is diagnosed as secondary and unlikely to have positive anti-PLA2R autoantibodies. This raises several questions: whether this patient has secondary MN associated with malignancy and coincidentally discovered anti-PLA2R autoantibodies, primary MN due to anti-PLA2R autoantibodies with coincidentally discovered malignancy, or whether malignancy can induce the formation of anti-PLA2R autoantibodies that result in MN. This case report highlights the importance of age-appropriate cancer screening, even in patients with presumed primary MN and positive anti-PLA2R autoantibodies.Lyle W. BakerJaime Jimenez-LopezXochiquetzal J. GeigerNabeel AslamKarger Publishersarticlemembranous glomerulonephritisanti-phospholipase-a2 receptor antibodiesmalignancyrenal cell carcinomanephrotic syndromeDiseases of the genitourinary system. UrologyRC870-923ENCase Reports in Nephrology and Dialysis, Vol 11, Iss 3, Pp 334-339 (2021)
institution DOAJ
collection DOAJ
language EN
topic membranous glomerulonephritis
anti-phospholipase-a2 receptor antibodies
malignancy
renal cell carcinoma
nephrotic syndrome
Diseases of the genitourinary system. Urology
RC870-923
spellingShingle membranous glomerulonephritis
anti-phospholipase-a2 receptor antibodies
malignancy
renal cell carcinoma
nephrotic syndrome
Diseases of the genitourinary system. Urology
RC870-923
Lyle W. Baker
Jaime Jimenez-Lopez
Xochiquetzal J. Geiger
Nabeel Aslam
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
description Membranous nephropathy (MN) is currently classified as either primary – often associated with positive anti-phospholipase-A2 receptor (PLA2R) autoantibodies – or as secondary – associated with malignancy, infection, medications, or autoimmune disease. We present a case of biopsy-proven MN with very high serum titer of anti-PLA2R autoantibodies in a patient with a synchronous diagnosis of poorly differentiated esophageal adenocarcinoma and renal cell carcinoma who presented with nephrotic syndrome. Based on the current classification, MN in the presence of active malignancy is diagnosed as secondary and unlikely to have positive anti-PLA2R autoantibodies. This raises several questions: whether this patient has secondary MN associated with malignancy and coincidentally discovered anti-PLA2R autoantibodies, primary MN due to anti-PLA2R autoantibodies with coincidentally discovered malignancy, or whether malignancy can induce the formation of anti-PLA2R autoantibodies that result in MN. This case report highlights the importance of age-appropriate cancer screening, even in patients with presumed primary MN and positive anti-PLA2R autoantibodies.
format article
author Lyle W. Baker
Jaime Jimenez-Lopez
Xochiquetzal J. Geiger
Nabeel Aslam
author_facet Lyle W. Baker
Jaime Jimenez-Lopez
Xochiquetzal J. Geiger
Nabeel Aslam
author_sort Lyle W. Baker
title Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
title_short Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
title_full Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
title_fullStr Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
title_full_unstemmed Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
title_sort malignancy-associated membranous nephropathy with positive anti-pla2r autoantibodies: coincidence or connection
publisher Karger Publishers
publishDate 2021
url https://doaj.org/article/233a25bf3d4949f692b2b338038fcfc1
work_keys_str_mv AT lylewbaker malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection
AT jaimejimenezlopez malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection
AT xochiquetzaljgeiger malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection
AT nabeelaslam malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection
_version_ 1718393729670184960